Lupin is introducing Minzoya (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets), 0.1 mg/0.02 mg and 36.5 mg, which is a generic of Avion’s Balcoltra. Generic Minzoya ...

Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

The company got the US Food and Drug Administration's nod for the 25 mg and the 50 mg dosages in October 2022. So far, only Lupin and Zydus Life have launched their generic versions of the drug.

Drug firm Lupin is recalling over six lakh bottles of a medication indicated for high blood pressure in the US due to deviation from current good manufacturing practices (CGMP), according to the ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan tablets for heart failure patients. Sacubitril and ...

According to IQVIA MAT December 2024, this drug will generate a U.S. market sales revenue of $1,374 million. Lupin is the first-to-file applicant for this generic product. Being the first-to-file ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) under the US President's Emergency Plan ... thereby significantly boosting our HIV medication portfolio," ...

Global pharma major Lupin Limited (Lupin) and Avas Pharmaceuticals SRL (Avas) today announced the launch of Lupin’s orphan drug NaMuscla® (mexiletine) in Italy. Avas will commercialize NaMuscla® for ...

India's Lupin beats Q2 profit view on strong demand for generic drugs November 7, 2024 India's benchmark indexes rose about 1% on Wednesday, snapping a three-session losing streak and a day late ...